ESC 365 - What is new in 2019 Guidelines on Diabetes, Pre-diabetes and Cardiovascular Diseases

Open Access

What is new in 2019 Guidelines on Diabetes, Pre-diabetes and Cardiovascular Diseases

Session: 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD)

Topic: Pharmacotherapy

Speaker: Professor F. Cosentino (Stockholm, SE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Francesco Cosentino

Karolinska University Hospital, Stockholm (Sweden)

30 presentations

3 followers

4 more presentations in this session

Management of dyslipidaemias.

Speaker: Doctor M. Lettino (Monza, IT)

New evidence from cardiovascular outcome trials.

Speaker: Professor N. Marx (Aachen, DE)

Benefits and risks of antithrombotic therapy in diabetes.

Speaker: Professor B. Rocca (Casamassima, IT)

Glucose-lowering drugs and heart failure.

Speaker: Professor P. Seferovic (Belgrade, RS)

Access the full session

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD)

Speakers: Professor F. Cosentino, Doctor M. Lettino, Professor N. Marx, Professor B. Rocca, Professor P. Seferovic

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources